MOG-IgG1 antibodies in children
Autores principales: | Waters, P, Fadda, G, Woodhalli, M, Irani, S, O'Mahony, J, Brown, R, Castro, D, Longoni, G, Yeh, E, Marrie, R, Arnold, D, Banwell, B, Bar-Or, A |
---|---|
Otros Autores: | Pediatric Demyelinating Disease Network |
Formato: | Conference item |
Publicado: |
SAGE Publications
2018
|
Ejemplares similares
-
Prospective clinical and MRI characterization of children with serum anti-MOG antibodies meeting the multiple sclerosis diagnostic criteria
por: Fadda, G, et al.
Publicado: (2018) -
Frequency of MOG-IgG in cerebrospinal fluid versus serum
por: Pace, S, et al.
Publicado: (2021) -
A multicenter comparison of MOG-IgG cell-based assays
por: Waters, P, et al.
Publicado: (2019) -
Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
por: Waters, P, et al.
Publicado: (2019) -
Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis
por: Hyun, J, et al.
Publicado: (2018)